Post-mortem findings in Spanish patients with COVID-19; a special focus on superinfections

Introduction Whole-body autopsies may be crucial to understand coronavirus disease 2019 (COVID-19) pathophysiology. We aimed to analyze pathological findings in a large series of full-body autopsies, with a special focus on superinfections. Methods This was a prospective multicenter study that included 70 COVID-19 autopsies performed between April 2020 and February 2021. Epidemiological, clinical and pathological information was collected using a standardized case report form. Results Median (IQR) age was 70 (range 63.75–74.25) years and 76% of cases were males. Most patients (90%,) had at least one comorbidity prior to COVID-19 diagnosis, with vascular risk factors being the most frequent. Infectious complications were developed by 65.71% of the patients during their follow-up. Mechanical ventilation was required in most patients (75.71%) and was mainly invasive. In multivariate analyses, length of hospital stay and invasive mechanical ventilation were significantly associated with infections (p = 0.036 and p = 0.013, respectively). Necropsy findings revealed diffuse alveolar damage in the lungs, left ventricular hypertrophy in the heart, liver steatosis and pre-infection arteriosclerosis in the heart and kidneys. Conclusion Our study confirms the main necropsy histopathological findings attributed to COVID-19 in a large patient series, while underlining the importance of both comorbid conditions and superinfections in the pathology.

[1]  U. Merle,et al.  Lethality of SARS‐CoV‐2 infection—a comparative autopsy study focusing on COVID‐19 development and virus variants , 2023, Histopathology.

[2]  I. Bougmiza,et al.  Histopathological Findings in COVID-19 Cases: A Systematic Review , 2022, Cureus.

[3]  M. Aepfelbacher,et al.  Organ manifestations of COVID-19: what have we learned so far (not only) from autopsies? , 2022, Virchows Archiv.

[4]  G. Guyatt,et al.  Effect of Early Treatment with Ivermectin among Patients with Covid-19 , 2022, The New England journal of medicine.

[5]  M. Baniecki,et al.  Oral Nirmatrelvir for High-Risk, Nonhospitalized Adults with Covid-19 , 2022, The New England journal of medicine.

[6]  J. Butterton,et al.  Molnupiravir for Oral Treatment of Covid-19 in Nonhospitalized Patients , 2021, The New England journal of medicine.

[7]  R. Menezes,et al.  Postmortem findings in COVID-19 fatalities: A systematic review of current evidence , 2021, Legal Medicine.

[8]  J. Zamorano,et al.  Late Cardiac Pathology in Severe Covid-19. A Postmortem Series of 30 Patients , 2021, Frontiers in Cardiovascular Medicine.

[9]  J. Arab,et al.  COVID-19 and Indirect Liver Injury: A Narrative Synthesis of the Evidence , 2021, Journal of clinical and translational hepatology.

[10]  V. Nag,et al.  Superinfections in COVID-19 Patients: Role of Antimicrobials , 2021, Dubai Medical Journal.

[11]  N. Casamitjana,et al.  Early Interventions and Impact of COVID-19 in Spain , 2021, International journal of environmental research and public health.

[12]  F. Sessa,et al.  Autopsy Tool in Unknown Diseases: The Experience with Coronaviruses (SARS-CoV, MERS-CoV, SARS-CoV-2) , 2021, Medicina.

[13]  P. Boor,et al.  Praktische Aspekte von COVID-19-Obduktionen , 2021, Der Pathologe.

[14]  F. Heppner,et al.  Causes of death and comorbidities in hospitalized patients with COVID-19 , 2021, Scientific Reports.

[15]  C. Clancy,et al.  Bacterial Superinfections Among Persons With Coronavirus Disease 2019: A Comprehensive Review of Data From Postmortem Studies , 2021, Open forum infectious diseases.

[16]  J. Ferreira,et al.  Tracking the time course of pathological patterns of lung injury in severe COVID-19 , 2021, Respiratory Research.

[17]  L. Pantanowitz,et al.  Postmortem Findings Associated With SARS-CoV-2 , 2021, The American journal of surgical pathology.

[18]  M. Trauner,et al.  COVID-19 autopsies: Procedure, technical aspects and cause of fatal course. Experiences from a single-center , 2020, Pathology - Research and Practice.

[19]  E. Turillazzi,et al.  Autopsy findings in COVID-19-related deaths: a literature review , 2020, Forensic Science, Medicine and Pathology.

[20]  W. Travis,et al.  Progression to fibrosing diffuse alveolar damage in a series of 30 minimally invasive autopsies with COVID‐19 pneumonia in Wuhan, China , 2020, Histopathology.

[21]  Colin G. White-Dzuro,et al.  Multisystem effects of COVID-19: a concise review for practitioners , 2020, Postgraduate medicine.

[22]  G. Ippolito,et al.  Postmortem Findings in Italian Patients With COVID-19: A Descriptive Full Autopsy Study of Cases With and Without Comorbidities , 2020, The Journal of infectious diseases.

[23]  M. Trauner,et al.  Post-mortem viral dynamics and tropism in COVID-19 patients in correlation with organ damage , 2020, Virchows Archiv.

[24]  J. Lacy,et al.  Histopathology and ultrastructural findings of fatal COVID-19 infections in Washington State: a case series , 2020, The Lancet.

[25]  Adenike O Eketunde,et al.  A Review of Postmortem Findings in Patients With COVID-19 , 2020, Cureus.

[26]  J. van Paassen,et al.  A systematic review of pathological findings in COVID-19: a pathophysiological timeline and possible mechanisms of disease progression , 2020, Modern Pathology.

[27]  R. Bruno,et al.  Remdesivir for 5 or 10 Days in Patients with Severe Covid-19 , 2020, The New England journal of medicine.

[28]  M. Hendaus,et al.  Covid-19 induced superimposed bacterial infection , 2020, Journal of biomolecular structure & dynamics.

[29]  L. Dodd,et al.  Remdesivir for the Treatment of Covid-19 — Final Report , 2020, The New England journal of medicine.

[30]  K. Mertz,et al.  Postmortem examination of COVID‐19 patients reveals diffuse alveolar damage with severe capillary congestion and variegated findings in lungs and other organs suggesting vascular dysfunction , 2020, Histopathology.

[31]  G. Li Volti,et al.  No Autopsies on COVID-19 Deaths: A Missed Opportunity and the Lockdown of Science , 2020, Journal of clinical medicine.

[32]  Kwok-Hung Chan,et al.  Triple combination of interferon beta-1b, lopinavir–ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19: an open-label, randomised, phase 2 trial , 2020, The Lancet.

[33]  Krishna M. Desai,et al.  Fatal Superimposed Bacterial Sepsis in a Healthy Coronavirus (COVID-19) Patient , 2020, Cureus.

[34]  Amit N. Patel,et al.  Cardiovascular Disease, Drug Therapy, and Mortality in Covid-19 , 2020, The New England journal of medicine.

[35]  R. Piarroux,et al.  Fatal Invasive Aspergillosis and Coronavirus Disease in an Immunocompetent Patient , 2020, Emerging infectious diseases.

[36]  V. S. Santos,et al.  Factors associated with mortality in patients with COVID-19. A quantitative evidence synthesis of clinical and laboratory data , 2020, European Journal of Internal Medicine.

[37]  Y. Ho,et al.  SARS-CoV-2: A Storm is Raging. , 2020, The Journal of clinical investigation.

[38]  Ke Ma,et al.  Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study , 2020, BMJ.

[39]  D. Raoult,et al.  Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial , 2020, International Journal of Antimicrobial Agents.

[40]  W. Tu,et al.  Clinical Features and Short-term Outcomes of 102 Patients with Corona Virus Disease 2019 in Wuhan, China , 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[41]  MingKun Li,et al.  Genomic diversity of SARS-CoV-2 in Coronavirus Disease 2019 patients , 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[42]  Zunyou Wu,et al.  Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention. , 2020, JAMA.

[43]  T. Velavan,et al.  The COVID‐19 epidemic , 2020, Tropical medicine & international health : TM & IH.

[44]  Y. Hu,et al.  Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China , 2020, The Lancet.

[45]  R. Hunter,et al.  The Importance of the Autopsy in Medicine: Perspectives of Pathology Colleagues , 2019, Academic pathology.

[46]  A. Katzenstein,et al.  Diffuse alveolar damage--the role of oxygen, shock, and related factors. A review. , 1976, The American journal of pathology.